Sandro Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$353K Sell
976
-15
-2% -$5.13K 0.26% 80
2026
Q1
$349K Sell
991
-40
-4% -$14.3K 0.28% 70
2025
Q4
$338K Buy
+1,031
New +$327K 0.28% 68

Other funds holding AMGN

Sandro Wealth Management's AMGN Position: Q2 2026 in Review

Sandro Wealth Management reduced its Amgen (AMGN) stake by 1.5% in Q2 2026, selling an estimated $5.13K and leaving 976 shares worth $353K. The position accounts for 0.26% of the portfolio, ranked #80.

Sandro Wealth Management first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sandro Wealth Management held 976 shares of Amgen worth $353K as of Q2 2026.
  • Sandro Wealth Management sold 15 Amgen shares in Q2 2026, an estimated $5.13K.
  • Amgen made up 0.26% of Sandro Wealth Management's portfolio in Q2 2026, its #80 holding.
  • Sandro Wealth Management first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sandro Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.